1. Home
  2. PTY vs FOLD Comparison

PTY vs FOLD Comparison

Compare PTY & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco Corporate & Income Opportunity Fund

PTY

Pimco Corporate & Income Opportunity Fund

HOLD

Current Price

$12.89

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.21

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTY
FOLD
Founded
2002
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
PTY
FOLD
Price
$12.89
$14.21
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$29.79
AVG Volume (30 Days)
550.4K
14.8M
Earning Date
01-01-0001
11-04-2025
Dividend Yield
9.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$598,704,000.00
Revenue This Year
N/A
$21.49
Revenue Next Year
N/A
$18.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.28
52 Week Low
$11.92
$5.51
52 Week High
$14.88
$14.36

Technical Indicators

Market Signals
Indicator
PTY
FOLD
Relative Strength Index (RSI) 30.64 91.10
Support Level $12.85 $10.64
Resistance Level $12.96 $11.14
Average True Range (ATR) 0.08 0.36
MACD -0.00 0.28
Stochastic Oscillator 9.78 96.46

Price Performance

Historical Comparison
PTY
FOLD

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: